Simulation of Plasmatic Enzyme Reactions During Thrombolytic Therapy With Recombinant Tissue-Type Plasminogen Activator: from In Vitro Knowledge To New Assumptions In Vivo

Abstract

Therapy of occlusive pathologies of blood vessels, like acute myocardial infarction, is commonly based on administration of thrombolytic enzymes that accelerate the dissolution of thrombi, but that increase also the risk of bleeding through their activity on specific plasma substances. In order to gain insight regarding the relative importance of various processes on the dynamics of these plasma substances we developed a math ematical model of biochemical reactions occurring in plasma during therapy with the thrombolytic agent rt-PA ( recombinant tissue-type Plasminogen Activator). On the basis of in vitro knowledge a preliminary model was formulated and simulation studies were performed to analyze in detail the various processes. During the validation of the model some novel hypotheses emerged regarding the importance of specific biochemical reactions in vivo. A revised model was then formulated which well describes experimental observations reported in literature.

Keywords

Bioengineering enzyme reactions thrombolytic therapy tissue- type plasminogen activator continuous time systems differential equations

Get full access to this article

View all access options for this article.

References

Agnelli, G. "Rationale for bolus rt-PA therapy to improve efficacy and safety." Chest 97:161S-167S, 1990.

Collen, D. "On the regulation and control of fibrinolysis ." Thromb. Haem. 43:77-89, 1980.

Gupta, G.K. ; Sacks-Davis, R. ; Tisher , P.E. "A review of recent developments in solving ODEs." ACM Computing Surveys 17:5-547, 1985.

Hindmarsh, A.C. "Odepack: a systematized collection of ode solvers ." Scientific Computing, Stepleman, R.S. et al. (eds.), Amsterdam, North-Holland, 1983, 55-64.

Hoylaerts, M. ; Rijken, D.C. ; Lijnen , H.R. ; Collen D. "Kinetics of activation of plasminogen by human tissue plasminogen activator." J. Biol. Chem. 257:2912-2919, 1982.

Loscalzo, J. "An overview of thrombolytic agents." Chest 97:117-123, 1990.

Marder, V.J. and Francis, C.W. "Physiological balance of haemostasis and bleeding." Drugs 33:13-21, 1987.

Noe, D.A. and Bell, W.R. "A kinetic analysis of fibrinogenolysis during plasminogen activator therapy." Clin. Pharmacol. Ther. 41:297-303, 1987.

Sobel, B.E. ; Gross, R.W. ; Robison A.K. "Thrombolysis, clot selectivity, and kinetics ." Circulation 70:160-164, 1984.

10.

Thomaseth, K. "PANSYM: a symbolic equation generator for mathematical modelling, analysis and control of metabolic and pharmacokinetic system." Comput. Methods Programs Biomed. 42:99-112, 1994.

11.

Thomaseth, K. "Modelling and analysis of physiological system with MATLAB: software development for Macintosh Computer." Modelling and Control in Biomedical System, Patterson, B.W. (ed.), Madison, Wisconsin Omnipress, 1994, pp. 408-409.

12.

Verstraete, M. ; Bounemeaux, H. ; De Cock , F. ; Van De Werf, F. ; Collen, D. "Pharmacokinetics and systemic fibrinogenolytic effects of recombinant human tissue-type plasminogen activator (rt-PA) in humans." J. Pharmacol. Exp. Ther. 235:506-512, 1985.

13.

Verstraete, M. ; Su, Capf , Tanswell , P. ; Feuerer, W. ; Collen, D. "Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteers." Thromb. Haem. 56:1-5, 1986.

14.

Wiman, B. ; Lijnen, H.R. ; Collen , D. "On the specific interaction between the lysine-binding sites in plasmin and complementary sites in α2 -antiplasmin and in fibrinogen ." Biochem. Biophys. Acta 579:142-154, 1979.